Trial Profile
Clinical Trials Insight: 700012682
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2006
Price :
$35
*
At a glance
- Drugs IMA 901 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors Immatics N.V.
- 20 Mar 2006 New trial record.